Home > Boards > US OTC > Miscellaneous >

Halberd Corp. (HALB)

Add HALB Price Alert      Hide Sticky   Hide Intro
Moderator: solidgold, EHRjunkie
Search This Board: 
Last Post: 5/24/2022 9:40:23 AM - Followers: 288 - Board type: Free - Posts Today: 3






Email: support@halberdcorporation.com

HALB Security Details - https://www.otcmarkets.com/stock/HALB/security

Share Structure

Authorized Shares -    800,000,000 - a/o 05/02/2022

Shares Outstanding -  513,650,338 - a/o 05/02/2022

Float-  320,542,712 - a/o 01/31/2022


 Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.            

HALB holds the exclusive rights to 3 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629

See YouTube video, https://youtu.be/BGdZqHH6oew, concerning Dr. Felder’s discussion of the scientific basis underlying Premier’s extracorporeal treatment process for fighting cancer and other diseases.


                                                                                                                                                                                                                                                         Halberd Corporation Pursues Extracorporeal Radio Frequency Treatment  Against Covid-19 | BioSpace

In plain English: Halberd Corporation is a biotechnology company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University) is developing an extra-corporeal (out of the body) treatment against PTSD, CTE, Alzheimer's Disease and other virusses and diseases. With the use of antibodies the disease antigens is targeted. Using radiofrequency / laser technology the "antibody-metallic moiety-antigens complex" is destroyed/eradicated. All based on 3 granted patents and 20 provisional (some PCT) patent applications.


Halberd Corporation's Proprietary Technology for Alzheimer's Disease Enters Stage 4 of 7 Stage Process

Jackson Center, Pennsylvania--(Newsfile Corp. - June 21, 2021) - Halberd Corporation's (OTC Pink: HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases), eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Currently, there is no known effective treatment for Alzheimer's Disease which afflicts over 40 million people worldwide, equivalent to the combined population of the states of Florida and New York.

                                                                                            The seven (7) stages in Halberd's program are as follows:

  1.                                                                                                                                                                              1. Identifying target disease(s); (Done yes)
                                                                                                                                                                                 2. Creating patentable antibodies vs target disease(s); (Done yes)
                                                                                                                                                                                 3. Combining antibodies with metallic particles; (Done yes)
                                                                                                                                                                                 4. Eradicating the antibody-disease combination through radiofrequency waves, laser or other proprietary means; (Done yes)
                                                                                                                                                                                 5. Conducting animal tests to establish the safety and efficacy; (Planning phase, contract with mci Consultants Inc for FDA regulations/process yes)

                                                                                                                                                                                 6. Conducting human testing
                                                                                                                                                                                 7. Obtaining FDA Certification


Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"


CEO William Hartman: "The principal competitive Alzheimer's drug treatment available today eliminates 5-15% of Beta Amyloid after one month of treatment costing over $50,000 per year. Halberd's extracorporeal process eradicates 100% within just 10 minutes."



* Halberd's on-going independent audit is anticipated to be completed within Q1 2022 yes

* Efforts are underway on filing Halberd's FORM-10 contingent on the completion of its independent audit leading to OTCQX exchange up-list by or within Q2 2022 yes

* Completion of the Top Ten Target Antigen elimination from CSF is expected to be completed within Q1 2022 yes

* Establish and execute meetings with the NFL and possibly the NCAA to seek endorsement for Halberd's PTSD/CTE research 

* Discussions have commenced and are in progress with a large medical university to develop potential cures for several neurodegenerative diseases with potential independent validation within the year 2022. We plan on sharing the name of this university once an agreement is established 

* We are looking into conducting initial discussions with an identified pharmaceutical company for potential partnering arrangements

* The next steps in Halberd's R&D program include eradication of the "Top Ten Target Antigens" from blood elements (serum and plasma)

* Plans are underway for generating scientific articles for publication within Q1 2022. The material will be carefully screened for patentable content prior to publication to protect our intellectual property and achievements

* Halberd is currently searching for an infectious disease specialist to be added to its company staff within Q1 2022 to assist in developing and testing cures for infectious diseases which have the potential of being treated with Halberd's proprietary technology yes

* Conclude current ongoing talks with a major university to acquire related abandoned intellectual property that could expand Halberd's value significantly

* Continue to protect Halberd's intellectual property by timely filing of patent applications











Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#25154  Sticky Note Halberd Submits Audited Financials; Files Form-10 as First solidgold 05/12/22 11:30:25 AM
#25174   $HALB Halberd Successfully Eliminates Excess Levels of Inflammatory Cytokines Louied91 05/24/22 09:40:23 AM
#25173   Halberd Successfully Eliminates Excess Levels of Inflammatory Cytokines subslover 05/24/22 08:50:51 AM
#25172   New Development. sundoctor 05/24/22 08:14:56 AM
#25171   who sell? who buy? MMs? sundoctor 05/21/22 05:30:01 PM
#25170   It was a sell, wasn't it? squidster 05/21/22 04:43:22 PM
#25169   Insider info. Perhaps a researcher on the project. gkare 05/21/22 10:28:12 AM
#25168   $HALB Halberd Engages Professional Firm to Proceed with Thugmuffin 05/21/22 07:19:58 AM
#25167   Run around $0.06 on Tuesday sundoctor 05/20/22 11:17:30 PM
#25166   Must be a PR coming Monday. gkare 05/20/22 09:18:19 PM
#25165   someone buy over 2million just before close sundoctor 05/20/22 05:48:16 PM
#25164   $HALB Halberd Engages Professional Firm to Proceed with Thugmuffin 05/19/22 09:52:37 PM
#25163   Let the truth set us free............ :) retired early 05/18/22 12:41:08 PM
#25162   $HALB Halberd Engages Professional Firm to Proceed with Louied91 05/18/22 09:43:12 AM
#25161   FDA Filings! GO HALB! sundoctor 05/18/22 08:28:52 AM
#25160   $HALB Halberd Submits Audited Financials; Files Form-10 as Thugmuffin 05/17/22 11:43:23 AM
#25159   What we're waiting for: * the step-by-step scenario EHRjunkie 05/17/22 08:06:12 AM
#25158   What we're waiting for: * partner news EHRjunkie 05/17/22 08:04:28 AM
#25157   What we're waiting for: * scientific article for EHRjunkie 05/17/22 08:04:00 AM
#25156   What we're waiting for: * government contract EHRjunkie 05/17/22 08:03:18 AM
#25155   no volume sundoctor 05/16/22 07:02:01 PM
#25154   Halberd Submits Audited Financials; Files Form-10 as First solidgold 05/12/22 11:30:25 AM
#25153   $HALB Halberd Submits Audited Financials; Files Form-10 as Louied91 05/12/22 09:25:04 AM
#25152   Halberd Submits Audited Financials; Files Form-10 as First subslover 05/12/22 08:41:22 AM
#25151   Thinking it’s just a ruse , so that work-n-hard 05/12/22 08:28:36 AM
#25150   Never get to OTCQX and are .005 away squidster 05/12/22 08:13:31 AM
#25149   Up-List to OTCQB! sundoctor 05/12/22 08:07:59 AM
#25148   Per the Master Agreement effective MM/DD/YYY, this IRP, Dinesh Malta 05/11/22 09:57:51 PM
#25147   Halberd has demonstrated the extracorporeal elimination from CSF, Dinesh Malta 05/11/22 09:37:36 PM
#25146   We anticipate opening clinical trial sites and enrolling Dinesh Malta 05/11/22 09:26:02 PM
#25145   Up listing to a better exchange. OTCQB Dinesh Malta 05/11/22 09:12:34 PM
#25144   Been tied up with personal stuff this week. You? work-n-hard 05/11/22 07:52:15 PM
#25143   Heard anything more about that $2 million grant squidster 05/11/22 07:50:24 PM
#25142   When $HALB becomes The Gold Standard for standard Dinesh Malta 05/10/22 09:42:45 AM
#25141   Buy more HALB at these bargain sale prices. Aero-man 05/09/22 02:29:59 PM
#25140   " with a lot more research, scratch that, work-n-hard 05/05/22 11:35:39 PM
#25139   All I saw was a babbling fool slightly squidster 05/05/22 09:22:30 PM
#25138   That's because the PPS, most times, follows the work-n-hard 05/05/22 09:21:46 AM
#25137   I saw the entire TED talk. Very impressive. bige777 05/04/22 09:04:42 PM
#25136   Last time it got near .01, it had work-n-hard 05/03/22 04:47:38 PM
#25135   MMs are playing and waiting for sth. see sundoctor 05/02/22 05:39:18 PM
#25134   Yes, it looks like Mr Hartman is patiently Aero-man 05/01/22 02:42:00 PM
#25133   The Tedx presentation with Dr Sturrus is a gkare 05/01/22 11:21:07 AM
#25132   These criminal-clot-shots being peddled by Pfizer, Moderna and Aero-man 04/30/22 02:16:51 PM
#25131   Dr. Gregg Sturrus' TEDx Talk(R) Features Halberd's Extracorporeal solidgold 04/29/22 08:21:47 PM
#25130   PR after PR, and the price descends. Wonder work-n-hard 04/29/22 09:44:59 AM
#25129   $HALB Dr. Gregg Sturrus' TEDx Talk(R) Features Halberd's Louied91 04/29/22 08:18:41 AM
#25128   Very promising from the talk! sundoctor 04/29/22 08:08:54 AM
#25127   https://www.otcmarkets.com/otcapi/company/financial-report/323418/content As of squidster 04/28/22 05:31:48 PM
#25125   Now, just need to increase the volume a little. work-n-hard 04/28/22 02:19:16 PM
#25124   I think the 5 day shows, it had work-n-hard 04/26/22 01:08:02 PM
Consent Preferences